Avalo Therapeutics, Inc.
0001534120 Nasdaq
정기공시
| 유형 | 보고서명 | 접수일 | 접수번호 | Pages |
|---|---|---|---|---|
| S-8 | 2025-05-12 | 0001628280-25-024441 | 5 | |
| S-8 | 2025-05-12 | 0001628280-25-024440 | 7 | |
| 10-Q | 2025-05-12 | 0001628280-25-024436 | 40 | |
| 8-K | 2025-05-12 | 0001628280-25-024435 | 4 | |
| 8-K | 2025-05-08 | 0001628280-25-023442 | 4 | |
| DEFA14A | 2025-05-01 | 0001628280-25-021313 | 4 | |
| DEF 14A | 2025-05-01 | 0001628280-25-021311 | 52 | |
| 4 | 2025-04-01 | 0001578563-25-000204 | 1 | |
| 4 | 2025-04-01 | 0001578563-25-000203 | 1 | |
| 4 | 2025-04-01 | 0001578563-25-000202 | 1 | |
| 4 | 2025-04-01 | 0001578563-25-000201 | 1 | |
| 4 | 2025-04-01 | 0001578563-25-000200 | 1 | |
| 4 | 2025-04-01 | 0001578563-25-000199 | 1 | |
| 4 | 2025-04-01 | 0001578563-25-000198 | 1 | |
| 4 | 2025-04-01 | 0001578563-25-000197 | 1 |
